Randomized, placebo-controlled study of Fentanyl Ethypharm for breakthrough pain in opioid-treated patients with cancer.
Phase of Trial: Phase III
Latest Information Update: 05 Feb 2014
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms ETHYFYL
- 05 Feb 2014 Primary endpoint 'Sum-of-pain-intensity-difference' has been met.
- 05 Feb 2014 Results published in the Clinical Therapeutics.
- 02 May 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01842893).